Poly (ADP) ribose synthetase inhibition reduces obliterative airway disease in rat tracheal allografts

Journal of Heart and Lung Transplantation

Volumn 23, Issue 8, 2004, Pages 993-1002

  Farivar, Alexander S ^a   Woolley, Steven M ^a   Naidu, Babu V ^a   Fraga, Charles H ^a   Byrne, Karen ^a   Thomas, Robert ^a   Salzman, Andrew L ^b   Szabo, Csaba S ^b   Mulligan, Michael S ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b INOTEK CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CYTOKINE; DNA NUCLEOTIDYLEXOTRANSFERASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INO 1001; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AUTOMATION; BRONCHIOLITIS; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; EXPERIMENTAL MODEL; EXPERIMENTAL TRANSPLANTATION; GEL MOBILITY SHIFT ASSAY; IN SITU HYBRIDIZATION; LUNG TRANSPLANTATION; MALE; MICROSCOPY; MORPHOMETRICS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; STAINING; STATISTICAL SIGNIFICANCE; TRACHEA; TRACHEA MUCOSA;

ANIMALS; BRONCHIOLITIS OBLITERANS; CASPASE 3; CASPASES; ELECTROPHORETIC MOBILITY SHIFT ASSAY; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; INDOLES; MALE; MODELS, ANIMAL; NF-KAPPA B; POLY(ADP-RIBOSE) POLYMERASES; POSTOPERATIVE COMPLICATIONS; RATS; RATS, INBRED LEW; RNA, MESSENGER; TRACHEA; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4243183504     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.08.009     Document Type: Conference Paper

References (21)

1. Pereszlenyi A., Harustiak S., Klepetko W. Circumstances of bronchiolitis obliterans development after lung transplantation. Bratisl Lek Listy. 101:2000;633-638
2. Chamberlain D.W. Lung transplantation pathology allograft evaluation. Patterson G.A., Courad L. Lung transplantation. 1995;307-324 Elsevier, Amsterdam
3. Tazelaar H.D., Prop J., Nieuwenhuis P., et al. Obliterative bronchiolitis in the transplanted rat lung. Transplant Proc. 19:1987;1052
4. Boehler A., Chamberlain D., Kesten S., et al. Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans. Transplantation. 64:1997;311-317
5. Satoh M.S., Lindahl T. Enzymatic repair of oxidative DNA damage. Cancer Res. 54:1994;1899-1901
6. Thiemermann C., Bowes J., Myint F.P., Vane J.R. Inhibition of the activity of poly (ADP) ribose synthetase reduces ischemia reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci. 94:1997;679-683
7. Mabley J.G., Jagtap P., Perretti M., et al. Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP) ribose polymerase. Inflamm Res. 50:2001;561-569
8. Oliver F.J., Murcia J.M., Nacci C., et al. Resistance to endotoxic shock as a consequence of defective NFκB activation in poly (ADP) ribose polymerase-1 deficient mice. EMBO J. 18:1999;4446-4454
9. Hele D.J., Yacoub M.H., Belvisi M.G. The heterotopic tracheal allograft as an animal model of obliterative bronchiolitis. Resp Res. 2:2001;169-183
10. Naidu B.V., Farivar A.S., Krishnadasan B.V., et al. Broad spectrum chemokine inhibition is protective against experimental obliterative bronchiolitis. Ann Thorac Surg. 75:(4):2003;1118-1122
11. Ikai K., Ueda K. Immunohistochemical demonstration of poly (ADP) ribose synthetase in bovine tissues. J Histochem Cytochem. 31:1983;1261-1264
12. Berger N.A. Oxidant induced cytotoxicity a challenge for metabolic modulation. Am J Resp Cell Molec Biol. 4:1991;1-3
13. Hyslop P.A., Hinshaw D.B., Halsey W.A., et al. Mechanisms of oxidant mediated cell injury the glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem. 263:1988;1665-1675
14. Berger N.A. Poly (ADP) ribose in the cellular response to DNA damage. Rad Res. 101:1985;4-15
15. Jagtap P., Soriano F.G., Virag L., et al. Novel phenanthridone inhibitors of poly (ADP) ribose synthetase potent cytoprotective and antishock agents. Crit Care Med. 30:2002;1071-1082
16. Zingarelli B., Cuzzocrea, Zsengeller Z., et al. Beneficial effect of inhibition of poly (ADP) ribose synthetase activity in myocardial ischemia-reperfusion injury. Cardiovasc Res. 6:1997;205-215
17. Liaudet L., Szabo A., Soriano F.G., et al. Poly (ADP) ribose synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock. 14:1999;134-141
18. Szabo C., Wong H., Bauer P.I., et al. Regulation of components of the inflammatory response by 5-iodo-6amino-1,2-benzopyrone, an inhibitor of PARS and pleiotropic modifier of cellular signal pathways. Int J Oncol. 10:1997;1093-1104
19. Roebuck K.A., Rahman A., Lakshminarayanan V., et al. Hydrogen peroxide and tumor necrosis factor alpha activate ICAM-1 gene transcription. J Biol Chem. 270:1995;18966-18974
20. Soriano F.G., Virag L., Jagtap P., et al. Diabetic endothelial dysfunction the role of PARS activation. Nature Med. 7:2001;108-113
21. Tikkanen J.M., Lemstrom K., Koskinen P. Blockade of CD 28/B72 costimulation inhibits experimental obliterative bronchiolitis in rat tracheal allografts. Am J Resp Crit Care Med. 165:(5):2002;724-729